BioMimetic Therapeutics Gives to School of Dentistry
The School of Dentistry has received some important funding from an industry partner. Anunrestricted grant from BioMimeticTherapeutics will support tissue engineering-related clinical research and education at the school. The funds will allow enhancement of a broad-based regeneration research program, further the exchange and development of ideas between academia and industry, and enable clinical studies of current and future bioregenerative systems.
“These funds will be used to develop and support pilot studies of periodontal and craniofacial applications of regenerative medicine,” says Michael Reddy, D.M.D., D.M.Sc., chair of the Department of Periodontology. “We have worked with BioMimetic Therapeutics for the past 10 years, and we are extremely grateful for their generous contribution to our research efforts.”
“Tissue engineering and regenerative medicine have the potential to tremendously advance the care of patients with injuries and tissue-destructive diseases such as periodontal disease,” says Sam Lynch, D.M.D., D.M.Sc., president and CEO of BioMimetic Therapeutics. “I believe that research and education in this area have the potential to greatly improve the care of patients with periodontal and maxillofacial defects in the immediate future.”
Lynch adds that he has tremendous respect for Dr. Reddy. “He is a very thoughtful researcher and clinician, and I am confident that he will put the funds to good use.”